Silk Road Medical Inc Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Silk Road Medical Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q2 2024.
  • Silk Road Medical Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11M, a 8.26% increase year-over-year.
  • Silk Road Medical Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $41.3M, a 25.3% increase year-over-year.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2023 was $38.9M, a 55.4% increase from 2022.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2022 was $25M, a 71.3% increase from 2021.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2021 was $14.6M, a 102% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $41.3M $11M +$842K +8.26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $40.4M $10.4M +$1.52M +17.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $38.9M $9.61M +$2.07M +27.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $36.8M $10.2M +$3.91M +61.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $32.9M $10.2M +$4.04M +65.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $28.9M $8.84M +$3.86M +77.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $25M $7.55M +$3.56M +89.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $21.5M $6.34M +$2.65M +72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $18.8M $6.16M +$2.75M +80.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $16.1M $4.98M +$1.45M +40.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $14.6M $3.98M +$1.71M +75.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $12.9M $3.69M +$1.68M +83.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $11.2M $3.41M +$1.76M +106% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $9.47M $3.53M +$2.24M +173% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $7.23M $2.27M +$1.32M +138% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $5.91M $2.01M +$1.08M +117% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $4.83M $1.65M +$818K +97.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $4.01M $1.29M +$1.03M +394% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.98M $954K +$728K +322% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.25M $925K +$731K +377% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.52M $836K +$507K +154% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.01M $262K +$100K +61.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $911K $226K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $194K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $329K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $162K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.